All bills
H.Con.Res. 225·108th Congress·House Concurrent Resolution

Expressing the sense of the Congress that the illegal importation of prescription drugs severely undermines the regulatory protections afforded to United States consumers, and for other purposes.

Stage not supplied

The source supplies the latest action, but no lifecycle stage.

Latest action (24 Jun 2003): Referred to the Subcommittee on Health.

What this bill does

This concurrent resolution, H.Con.Res. 225, expresses a non-binding opinion of Congress. It states that the illegal importation of prescription drugs harms consumer protections. The resolution calls for the President to take action to stop illegal drug imports from foreign countries for national security and consumer protection reasons. It also asks the United States Trade Representative to address pricing policies in Canada that are described as discriminatory and harmful to the U.S. pharmaceutical industry.

The resolution further suggests that the pharmaceutical industry and healthcare community should launch an educational campaign about the risks of imported drugs and work to lower prescription drug prices for U.S. consumers. It emphasizes the importance of affordable access to prescription drugs for U.S. patients and states that Congress should enact a Medicare drug benefit as the safest way for patients to obtain their medications.

Introduced in the House of Representatives in June 2003 by Representative Gregory W. Meeks, the bill was referred to committees. It was subsequently referred to a subcommittee. As a concurrent resolution, it requires agreement from both the House and the Senate to be formally adopted, expressing the sense of Congress.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Timeline

  1. 24 Jun 2003

    Referred to the Subcommittee on Health.

Common questions

What does H.Con.Res. 225 do?
This concurrent resolution, H.Con.Res. 225, expresses a non-binding opinion of Congress. It states that the illegal importation of prescription drugs harms consumer protections. The resolution calls for the President to take action to stop illegal drug imports from foreign countries for national security and consumer protection reasons. It also asks the United States Trade Representative to address pricing policies in Canada that are described as discriminatory and harmful to the U.S. pharmaceutical industry. The resolution further suggests that the pharmaceutical industry and healthcare community should launch an educational campaign about the risks of imported drugs and work to lower prescription drug prices for U.S. consumers. It emphasizes the importance of affordable access to prescription drugs for U.S. patients and states that Congress should enact a Medicare drug benefit as the safest way for patients to obtain their medications. Introduced in the House of Representatives in June 2003 by Representative Gregory W. Meeks, the bill was referred to committees. It was subsequently referred to a subcommittee. As a concurrent resolution, it requires agreement from both the House and the Senate to be formally adopted, expressing the sense of Congress.
Has H.Con.Res. 225 become law?
The source does not supply a confirmed lifecycle stage for H.Con.Res. 225. Check the latest action and official source below.
Who sponsored H.Con.Res. 225?
H.Con.Res. 225 was sponsored by Rep. Meeks, Gregory W. [D-NY-6] (D-NY), with 0 cosponsors.
What's the latest action on H.Con.Res. 225?
Referred to the Subcommittee on Health. (24 Jun 2003).

Related bills in Foreign Trade and International Finance

More bills from Rep. Meeks, Gregory W. [D-NY-6]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.